Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07489482

A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection

A Randomized, Parallel, Open-label Clinical Study on the Bioavailability and Safety of Different Specifications of SHR-3167 Injection in Healthy Subjects

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Jiangsu HengRui Medicine Co., Ltd. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study is a randomized, parallel, open-label Phase I clinical trial aimed at comparing the bioavailability and safety of different specifications of SHR-3167 injection, with healthy subjects as the research subjects.

Conditions

Interventions

TypeNameDescription
DRUGSHR-3167 InjectionSHR-3167 injection, different specifications.

Timeline

Start date
2026-03-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2026-03-24
Last updated
2026-03-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07489482. Inclusion in this directory is not an endorsement.

A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection (NCT07489482) · Clinical Trials Directory